Mir-28-5p promotes chromosomal instability in vhl-Associated cancers by inhibiting mad2 translation

Cancer Research

Volumn 74, Issue 9, 2014, Pages 2432-2443

  Hell, Michael P ^a   Thoma, Claudio R ^a   Fankhauser, Niklaus ^a   Christinat, Yann ^a   Weber, Thomas C ^a   Krek, Wilhelm ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 28 5P; PROTEIN MAD2; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; CELL CYCLE CHECKPOINT; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CHROMOSOME MISSEGREGATION ERROR; CONTROLLED STUDY; GENE EXPRESSION; IN VIVO STUDY; KIDNEY CARCINOMA; KIDNEY INJURY; KNOCKOUT MOUSE; M PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM;

3' UNTRANSLATED REGIONS; ANEUPLOIDY; ANIMALS; CARCINOMA, RENAL CELL; CELL CYCLE CHECKPOINTS; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; FEMALE; HCT116 CELLS; HELA CELLS; HUMANS; KIDNEY NEOPLASMS; MAD2 PROTEINS; MICE; MICE, KNOCKOUT; MICRORNAS; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; RNA INTERFERENCE; RNA, SMALL INTERFERING; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84900017935     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2041     Document Type: Article

References (46)

1. Gordon DJ, Resio B, Pellman D. Causes and consequences of aneuploidy in cancer. Nat Rev Genet 2012;13:189-203.
2. Rieder CL, Cole RW, Khodjakov A, Sluder G. The checkpoint delaying anaphase in response to chromosome monoorientation ismediated by an inhibitory signal produced by unattached kinetochores. J Cell Biol 1995;130:941-8.
3. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007;8:379-93. (Pubitemid 46643240)
4. Lara-Gonzalez P, Westhorpe FG, Taylor SS. The spindle assembly checkpoint. Curr Biol 2012;22:R966-80.
5. Thoma CR, Toso A, Gutbrodt KL, Reggi SP, Frew IJ, Schraml P, et al. VHL loss causes spindle misorientation and chromosome instability. Nat Cell Biol 2009;11:994-1001.
6. Furlong F, Fitzpatrick P, O'Toole S, Phelan S, McGrogan B, Maguire A, et al. Low MAD2 expression levels associate with reduced progression- free survival in patients with high-grade serous epithelial ovarian cancer. J Pathol 2012;226:746-55.
7. Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kondo S, et al. Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients. Lung Cancer (Amsterdam, Netherlands) 2011;74:124-31.
8. Wang L, Yin F, Du Y, Du W, Chen B, Zhang Y, et al. MAD2 as a key component of mitotic checkpoint: a probable prognostic factor for gastric cancer. Am J Clin Pathol 2009;131:793-801.
9. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001;409:355-9. (Pubitemid 32151241)
10. Sotillo R, Hernando E, Diaz-Rodriguez E, Teruya-Feldstein J, Cordon- Cardo C, Lowe SW, et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007;11:9-23. (Pubitemid 46054519)
11. 53 pathway inhibition. Cancer Cell 2011;19:701-14.
12. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009;373:1119-32.
13. Frew IJ, Thoma CR, Georgiev S, Minola A, Hitz M, Montani M, et al.pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO J 2008;27:1747-57.
14. Hell MP, Duda M, Weber TC, Moch H, Krek W. Tumor suppressor VHL functions in the control of mitotic fidelity. Cancer Res 2014;74:2422-31.
15. Moralli D, Yusuf M, Mandegar MA, Khoja S, Monaco ZL, Volpi EV. An improved technique for chromosomal analysis of human ES and iPS cells. Stem Cell Rev 2011;7:471-7.
16. Ricke RM, Jeganathan KB, Malureanu L, Harrison AM, van Deursen JM. Bub1 kinase activity drives error correction and mitotic checkpoint control but not tumor suppression. J Cell Biol 2012;199: 931-49.
17. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007;27:91-105. (Pubitemid 46991392)
18. Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006;34:W451-4.
19. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 2007;17:1665-74. (Pubitemid 350074862)
20. Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson A, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499:43-9. 21. Mood AM. On the asymptotic efficiency of certain nonparametric twosample tests. Ann Math Stat 1954;25:514-22.
21. Pestova TV, Kolupaeva VG, Lomakin IB, Pilipenko EV, Shatsky IN, Agol VI, et al. Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci U S A 2001;98:7029-36. (Pubitemid 32567898)
22. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011;12:99-110.
23. Fabian MR, Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012;19:586-93.
24. Hagan RS, Manak MS, Buch HK, Meier MG, Meraldi P, Shah JV, et al. p31(comet) acts to ensure timely spindle checkpoint silencing subsequent to kinetochore attachment. Mol Biol Cell 2011;22:4236-46.
25. Shao X, Somlo S, Igarashi P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 2002;13:1837-46. (Pubitemid 34700608)
26. Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, et al. Patterns of gene expression and copy-number alterations in vonhippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 2009;69:4674-81.
27. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010;17:362-75.
28. 53 alleles. Cell 1992;70:937-48.
29. Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, Goeman JJ, et al. Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLoS ONE 2012;7: e38298.
30. Beleut M, Zimmermann P, Baudis M, Bruni N, Buhlmann P, Laule O, et al. Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome. BMC Cancer 2012;12:310.
31. Ruddy DA, Gorbatcheva B, Yarbrough G, Schlegel R, Monahan JE. No somatic mutations detected in the Mad2 gene in 658 human tumors. Mutat Res 2008;641:61-3.
32. Sotillo R, Schvartzman JM, Socci ND, Benezra R. Mad2-inducedchromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 2010;464:436-40.
33. Mukherji S, Ebert MS, Zheng GX, Tsang JS, Sharp PA, van Oudenaarden A. MicroRNAs can generate thresholds in target gene expression. Nat Genet 2011;43:854-9.
34. Collin P, Nashchekina O, Walker R, Pines J. The spindle assembly checkpoint works like a rheostat rather than a toggle switch. Nat Cell Biol 2013;15:1378-85.
35. Heinrich S, Geissen EM, Kamenz J, Trautmann S, Widmer C, Drewe P, et al. Determinants of robustness in spindle assembly checkpoint signalling. Nat Cell Biol 2013;15:1328-39.
36. Dick AE, Gerlich DW. Kinetic framework of spindle assembly checkpoint signalling. Nat Cell Biol 2013;15:1370-7.
37. Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, et al. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J Biol Chem 2010;285: 39551-63.
38. Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG, Hur MW. Protooncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem 2008;283: 33199-210.
39. Kaelin WG. Von Hippel-Lindau disease. Annu Rev Pathol 2007;2: 145-73.
40. Pena-Llopis S, Vega-Rubin-De-Celis S, Liao A, Leng N, Pavia-Jimenez A, Wang S, et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2012;44:751-9.
41. Varela I, Tarpey P, Raine K, Huang D,Ong CK, Stephens P, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011;469:539-42.
42. Dobles M, Liberal V, Scott ML, Benezra R, Sorger PK. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 2000;101:635-45.
43. Wilting SM, Snijders PJ, Verlaat W, Jaspers A, van de Wiel MA, van Wieringen WN, et al. Altered microRNA expression associated withchromosomal changes contributes to cervical carcinogenesis. Oncogene 2013;32:106-16.
44. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, Meyer HE, et al. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol (Zurich, Switzerland) 2010;20:539-50.
45. Li Z, Gu X, Fang Y, Xiang J, Chen Z. microRNA expression profiles inhuman colorectal cancers with brain metastases. Oncol Lett 2012;3: 346-50.
46. Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafa R, et al. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 2012;142:886-96 e9.